Istiratumab
Istiratumab (M-6495) is a bispecific monoclonal antibody against IGF-1R and ErbB3 that induces degradation of IGF-1R and ErbB3 receptors through the proteasomal pathway and can be used in cancer research.
Supplier | Alfa Cytology |
---|---|
Product # | PC0126 |
Pricing | 1 mg, 5 mg,10 mg, inquire |